In patients with severe coronary artery disease, in who we quantify a number of dysmetabolic and inflammatory markers and test of endothelial dysfunction, it was observed that the only differences between patients with and without abdominal obesity was a decrease in plasma concentrations of adiponectin and an increase in leptin plasma levels present in patients with abdominal obesity. The gene discussed is ADIPOQ; the disease is endothelial dysfunction.